{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} Menopausal Hormone Therapy for Vasomotor Symptoms: 18 Years After the Women's Health Initiative

Activity Steps


NOTE: This activity requires payment before viewing.

Learning Objectives

After completing this continuing education activity you will be able to:

  1. Identify the pathophysiology and risk factors associated with menopausal vasomotor symptoms.
  2. Explain the risks and benefits of menopausal hormone therapy (MHT).
  3. Plan MHT treatment options for postmenopausal patients experiencing symptoms caused by estrogen deprivation.
Price: $49.00


  • ANCC 2.5 CH / 2.5 APH
  • DC - BON 2.5 CH
  • FL - BON 2.5 CH
  • GA - BON 2.5 CH

Lippincott Professional Development is accredited with distinction as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation. This activity is also provider approved by the California Board of Registered Nursing, Provider Number CEP 11749. Lippincott Professional Development is also an approved provider of continuing nursing education by the District of Columbia Board of Nursing, Florida Board of Nursing, and Georgia Board of Nursing, #50-1223.

Awarded Advanced Pharmacology Hours

Test Code: PGO0521B
Published: May 2021
Expires: 3/3/2023
Required Passing Score: 7/10 (70%)
Authors: Kayla Ostiller, BS; Alexandra Lebental, MD; Marisa Z. Rose, MD